Park Square has placed Ronald Herbst as Chief Scientific Officer at Pyxis Oncology.
Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel...…
Tiaki Therapeutics has appointed Suzanne Bruhn as CEO. Bruhn, a serial biotech CEO, arrives at Tiaki shortly after the Alzheimer’s...
Park Square is pleased to announce the placement of Michael Cox as Vice President, Clinical Development at Puma Biotechnology. Puma...
Interesting discussion around some of the techniques and technologies being used to create a pipeline of new crops to help improve food...
Park Square has placed Daniel Orlando as Chief Executive Officer at Alcresta Therapeutics.
Alcresta Therapeutics Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products,...…
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net